Inventor · disambiguated record
Michael Scott Visser
Also filed as: VISSER MICHAEL S · VISSER MICHAEL SCOTT
17 granted patents·10 pending applications·82 citations·filing 2001–2025
93Inventor score
Top patents by PatentIndex Score
27 records- 0196US10414755B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2018·Granted Sep 17, 2019·18 cites·25 claims
- 0295US11053218B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2020·Granted Jul 6, 2021·4 cites·21 claims
- 0395US10647701B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2019·Granted May 12, 2020·13 cites·16 claims
- 0495US10640489B23-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2019·Granted May 5, 2020·13 cites·64 claims
- 0594US9845309B2Protein kinase C inhibitors and methods of their useNOVARTIS AG·Filed 2016·Granted Dec 19, 2017·6 cites·17 claims
- 0692US10508101B2Protein kinase C inhibitors and methods of their useNOVARTIS AG·Filed 2019·Granted Dec 17, 2019·3 cites·23 claims
- 0790US11059804B2Protein kinase C inhibitors and methods of their useNOVARTIS AG·Filed 2019·Granted Jul 13, 2021·3 cites·21 claims
- 0890US9452998B2Protein kinase C inhibitors and methods of their useVISSER MICHAEL SCOTT·Filed 2015·Granted Sep 27, 2016·6 cites·18 claims
- 0989US11192877B23-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2019·Granted Dec 7, 2021·6 cites·16 claims
- 1088US11505541B2Protein kinase C inhibitors and methods of their useNOVARTIS AG·Filed 2021·Granted Nov 22, 2022·1 cites·20 claims
- 1186US2024308979A1Protein kinase c inhibitors and methods of their useNOVARTIS AG·Filed 2023·Application pending·0 cites
- 1279US9181266B22-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitorsCHEUNG ATWOOD KIM·Filed 2012·Granted Nov 10, 2015·3 cites·13 claims
- 1379US2025248996A1Protein kinase c inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1478US11413284B2Protein kinase C inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2018·Granted Aug 16, 2022·2 cites·16 claims
- 1576US12208097B2Protein kinase C inhibitors for treatment of uveal melanomaNOVARTIS AG·Filed 2022·Granted Jan 28, 2025·0 cites·16 claims
- 1673US2021309638A13-(1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1769US2018179181A1Protein kinase c inhibitors and methods of their useNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1865US8809352B2Sulfonamides as inhibitors of Bcl-2 family proteins for the treatments of cancerMILLER-MOSLIN KAREN·Filed 2010·Granted Aug 19, 2014·2 cites·4 claims
- 1963US6867230B2Hygromycin A derivativesPFIZER·Filed 2001·Granted Mar 15, 2005·2 cites·8 claims
- 2061US2025289802A13-(1-oxo-5-(piperidin-4-yl)isoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2025·Application pending·0 cites
- 2155US2022144807A13-(1-oxo-5-(piperidin-4-yl)isoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 2249US2014350014A1Compounds for inhibiting the interaction of bcl2 with binding partnersNOVARTIS AG·Filed 2012·Application pending·0 cites
- 2345US2004220186A1PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular diseasePFIZER·Filed 2004·Application pending·0 cites
- 2444US9126979B2Compounds for inhibiting the interaction of BCL2 with binding partnersNOVARTIS AG·Filed 2012·Granted Sep 8, 2015·0 cites·17 claims
- 2544US9126980B2Compounds for inhibiting the interaction of BCL2 with binding partnersNOVARTIS AG·Filed 2012·Granted Sep 8, 2015·0 cites·12 claims
- 2642US2014357633A1Compounds for inhibiting the interaction of bcl2 with binding partnersNOVARTIS AG·Filed 2012·Application pending·0 cites
- 2737US2014357666A1Compounds for inhibiting the interaction of bcl2 with binding partnersVISSER MICHAEL SCOTT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Scott Visser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →